Citation:Schadendorf D, Long GV, Stroiakovski D, Karaszewska B, Hauschild A, Levchenko E, et al 2017

From Cancer Guidelines Wiki

Jump to:navigation, search

Citation

Schadendorf D, Long GV, Stroiakovski D, Karaszewska B, Hauschild A, Levchenko E, et al. Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials. Eur J Cancer 2017 Sep;82:45-55 Available from: http://www.ncbi.nlm.nih.gov/pubmed/28648698.

Critical appraisals

Assign a critical appraisal

Compare quality appraisals for each clinical question

Cited by

Targeted therapies for melanoma

Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Schadendorf_D,_Long_GV,_Stroiakovski_D,_Karaszewska_B,_Hauschild_A,_Levchenko_E,_et_al_2017&oldid=169944"